Annovis BioANVS
13F holders, Q2 2024 (June 30)31holders
6new positions
6sold out
$5.76avg. 13F price*
At the end of Q2 2024, 31 institutions reported holding Annovis Bio (ANVS) in their 13F filings, unchanged from Q1 2024. 6 opened new positions and 6 sold out. The largest holders were Vanguard Group Inc. ($2.1M), BlackRock Inc. ($580K) and Adage Capital Partners Gp, L.L.C. ($576K).
- Company
- Annovis Bio
- CUSIP
- 03615A108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $208K |
| Exits | 6 | $1.5M |
All 13F filers, Q1 2024 → Q2 2024: 65,118 shares bought and 293,768 shares sold, net −228,650 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Vanguard Group Inc. | 0.00% | Add +0.9% | 361,354 | $2.1M |
| BlackRock Inc. | 0.00% | Add +3.1% | 100,709 | $580K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Reduce -60.0% | 100,000 | $576K |
| Geode Capital Management, LLC | 0.00% | Add +7.7% | 76,233 | $439K |
| Wescott Financial Advisory Group, LLC | 0.03% | No change | 41,607 | $240K |
| Sterling Investment Advisors, Ltd. | 0.05% | Reduce -2.6% | 33,474 | $193K |
| Modera Wealth Management, LLC | 0.00% | No change | 30,513 | $176K |
| State Street Corp. | 0.00% | No change | 29,135 | $168K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -34.2% | 22,100 | $127K |
| Merit Financial Group, LLC | 0.00% | Reduce -2.3% | 21,700 | $125K |
| XTX Topco Ltd | 0.01% | New | 19,907 | $115K |
| Northern Trust Corp. | 0.00% | Reduce -20.7% | 19,235 | $111K |
| Bank of New York Mellon Corp | 0.00% | No change | 19,059 | $110K |
| Greenwich Wealth Management LLC | 0.01% | Add +19.9% | 15,075 | $87K |
| Cannell & Spears LLC | 0.00% | No change | 15,000 | $86K |
| UBS Group AG | 0.00% | Add +2065.0% | 12,990 | $75K |
| Lokken Investment Group LLC | 0.03% | No change | 12,235 | $70K |
| Jane Street Group, LLC | 0.00% | New | 10,123 | $58K |
| Wealthspire Advisors, LLC | 0.00% | No change | 10,000 | $58K |
| Wells Fargo & Company | 0.00% | Reduce -0.6% | 8,747 | $50K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +42.9% | 6,858 | $40K |
| Morgan Stanley | 0.00% | Reduce -23.2% | 5,498 | $32K |
| Bank of America Corp. | 0.00% | Reduce -8.1% | 5,065 | $29K |
| Belvedere Trading LLC | 0.00% | New | 4,778 | $28K |
| Osaic Holdings, Inc. | 0.00% | Add +6.3% | 1,275 | $7K |
| Opal Wealth Advisors, LLC | 0.00% | New | 1,000 | $6K |
| Game Plan Financial Advisors, LLC | 0.00% | No change | 200 | $1K |
| FMR LLC | 0.00% | New | 200 | $1K |
| WR Wealth Planners, LLC | 0.00% | No change | 150 | $864 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 83 | $773 |
| Royal Bank of Canada | 0.00% | Add +1700.0% | 72 | $0 |
"% of holder's portfolio" is ANVS's weight in each manager's 13F, not the share of Annovis Bio the manager owns.